Ampli®cation and overexpression of genes involved in cellular growth control occur frequently in human cancers. Here, we report characterization of the full length OS4 cDNA derived from 12q13-q15 (Su et al., Proc. Natl. Acad. Sci. USA, 91: 9121 ± 9125, 1994), a region frequently ampli®ed in sarcomas and brain tumors. This cDNA consists of 4833 base pairs (bp) encoding an open reading frame (ORF) of 283 amino acids. The ORF predicts a water-soluble acidic (pI 5.50) polypeptide with a molecular weight of 31 759. Database searches revealed highly signi®cant similarity between OS4 and eight proteins predicted from genomic sequences of Caenorhabditis elegans, Schizosaccaharomyces pombe, and Saccharomyces cerevisiae. Thus, OS4 de®nes a novel evolutionarily conserved gene superfamily. Northern and database analyses revealed OS4 transcripts in numerous human tissues demonstrating its ubiquitous expression. We also observed overexpression of OS4 in three cancer cell lines with ampli®cation of this gene. Furthermore, we detected OS4 ampli®cation in 5/5 primary sarcomas with known ampli®cation of the closely linked marker CDK4. These results demonstrate that the highly conserved OS4 gene is frequently included in the 12q13-q15 amplicon and may contribute to the development of a subset of sarcomas.
Introduction
In human cancers, gene ampli®cation is a common mechanism by which increased dosage of a gene leads to its overexpression. Ampli®cation of cellular oncogenes has been observed in tumor cell lines and primary tumor tissues suggesting that overexpression of these genes provides tumor cells with a selective growth advantage in vitro and in vivo. The chromosome 12q13-q15 region is frequently ampli®ed in human sarcomas and brain tumors (Smith et al., 1992; Reifenberger et al., 1994) . Several genes have been previously mapped to this region, including a zinc ®nger protein (GLI [Roberts et al., 1989] ), a member of the transmembrane four superfamily (SAS [Meltzer et al., 1991; Jankowski et al., 1994] ), a cyclin dependent kinase (CDK4 [Khatib et al., 1993] ), a transcription factor (CHOP [Aman et al., 1992] ), a modulator of p53 (MDM2 [Oliner et al., 1992; Leach et al., 1993] ), and two novel genes (OS9 and OS4) (Su et al., 1994 (Su et al., , 1996 . Recently, we have demonstrated that this amplicon is derived from a gene-rich locus, encoding several additional ampli®ed cDNAs (Gracia et al., 1996) .
Full characterization of ampli®ed DNA in tumors requires mapping of the involved genomic segments to identify the genes contained in the core region which is consistently ampli®ed in multiple tumors. Expression and functional studies are then required to interpret the relative importance of those genes which consistently contribute to the amplicon. Physical mapping studies have demonstrated that 12q13-q15 amplicons contain two separate core regions, a telomeric region containing MDM2 and a centromeric region containing CDK4 . These regions are separated by over 1 Mb, and markers in variable portions of the intervening segment are frequently not ampli®ed. Currently, because of their roles in regulating the cell cycle (MDM2 through p53, and CDK4 through pRb) these genes are considered the most probable target genes for 12q13-q15 ampli®cation. However, the CDK4 core region is quite gene dense, and several closely linked genes are typically co-ampli®ed (Berner et al., 1996) . We have been pursuing the complete characterization of the CDK4 core region in order to evaluate the potential impact of the genes in this region on tumor phenotype. OS4 which we originally identi®ed by chromosome microdissection and hybrid selection falls in the CDK4 core region, and we therefore pursued characterization of a full length cDNA clone. The 4833-bp OS4 cDNA encodes an ORF of 283 amino acid residues. Our analysis revealed OS4 expression in multiple dierent human tissues and its overexpression in three cancer cell lines with OS4 ampli®cation. By Southern hybridization, we demonstrated ampli®cation of OS4 in 5/5 primary sarcomas with known CDK4 ampli®cation. Finally, database searches demonstrate highly signi®cant similarity of OS4 with eight genes in organisms as divergent as S. cerevisiae, strongly suggesting that these genes belong to an evolutionarily conserved superfamily.
Results

OS4 cDNA sequence
The 4833-bp sequence of the full length OS4 cDNA was determined from the concensus sequence of both strands of 57 plasmids containing overlapping OS4 cDNA inserts. The full length cDNA consists of three segments: a 305-bp 5'-untranslated region (5'-UTR: 1 ± 305), a 849-bp coding sequence (306 ± 1154), and a 3679-bp 3'-untranslated region (3'-UTR: 1155 ± 4833).
The 305-bp 5'-UTR is GC-rich (72% GC content) and contains several direct repeats. The OS4 ORF encodes 283 amino acids (Figure 1 ) with a predicted molecular weight of 31.8 kD and pI 5.50. No hydrophobic segment longer than 10 amino acid residues was presented suggesting that the OS4 protein is probably water soluble.
Database research revealed highly signi®cant similarity of the OS4 ORF with eight ORFs deduced from genomic sequences of C. elegans, S. pombe, and S. cerevisiae (Figure 2 ). (Figure 2a indicates the alignment of OS4 with these ORFs underlining the presence of three highly conserved regions (HC1, HC2 and HC3). HC1, HC2 and HC3 contains 76.5% (13/17), 56.8% (21/37), and 52.3% (23/44) identical residues, respectively, in six or more proteins of these nine ORFs (Figure 2b ). Out of these nine ORFs, four are from S. cerevisiae (two acidic, one neutral, and one basic), and three ORFs are from C. elegans (acidic, neutral, and basic). The human and S. pombe ORFs are acidic. In addition, two of the predicted polypeptides (F45E12.1 and YHR004c) contain a hydrophobic segment (25 to 35 residues) within the amino terminal region suggesting possible membrane anchorage.
Although comparison of the OS4 cDNA sequence with the current GenBank database using the BLAST programs (Altschul et al., 1990) revealed no signi®cant identity to any gene with known function, a comparison with the EST (expressed sequence tag) database revealed highly signi®cant alignments with over 100 ESTs (P-values: 10 710 to 10
7198
). These ESTs were derived from 22 dierent adult, infant, and fetal tissues, indicating ubiquitous expression of OS4. In addition, several highly similar ESTs from mouse and rat were also identi®ed by sequence alignment (data not shown).
Ubiquitous expression of OS4
To examine the expression of OS4, Northern blots containing poly(A) + RNA from adult normal tissues and cancer cell lines were hybridized with the OS4 probe. The result demonstrated similar levels of OS4 transcripts in most of 16 normal tissues examined except that the levels was twofold lower in brain and lung, fourfold lower in liver, and more than fourfold higher in pancreas ( Figure 3a ). The levels of OS4 transcripts in eight cancer cell lines were also similar except for a somewhat lower level in the lung carcinoma A549 (Figure 3b ).
Over-expression of both OS4 and CDK4 in cancer cell lines with ampli®cation of these genes Cancer cell lines with or without OS4 and CDK4 ampli®cation were used to study the expression of these two genes by Northern hybridization. The amplification of OS4 and CDK4 in several cancer cell lines including NGP-127 (neuroblastoma) (Su et al., 1994) , OsA-Cl (osteosarcoma) (Su et al., 1994) , and RMS-13 (rhabdomyosarcoma) have been previously reported. The levels of OS4 and CDK4 transcripts from these ampli®ed cell lines were compared with three normal tissues (spleen, pancreas, and skeletal muscle) and with the osteosarcoma cell lines U-2 OS (Ponten and Saksela, 1967) and HOS (Rhim et al., 1975) which had no Southern-detectable ampli®cation of OS4 and CDK4 (data not shown). The results from Northern hybridization demonstrated overexpression of both OS4 and CDK4 in the ampli®ed cancer cell lines NGP-127, OsA-Cl, and RMS-13 (Figure 4 ). After normalization relative to bactin, expression of OS4 and CDK4 was estimated by densitometry to be at least tenfold higher in the ampli®ed cell lines than in the non-ampli®ed lines and the normal tissues.
Ampli®cation of OS4 and CDK4 in primary sarcomas
Since OS4 and CDK4 are linked within 60 kb , Southern analysis to evaluate co-ampli®cation of OS4 with CDK4 was performed on DNA samples isolated from ®ve dierent human primary sarcomas with CDK4 ampli®cation previously identi®ed by screening with a CDK4 probe. The result demonstrated the ampli®cation of OS4 in all ®ve primary sarcomas tested consistent with its presence within the core region of ampli®cation ( Figure 5 ). Figure 1 The predicted 283 amino acid sequence of the OS4 ORF. The underlined residues in the amino acid sequence correspond to three highly conserved regions illustrated in Figure 2a and 2b. The map illustrates the chromosomal order and approximate positions of OS4 and three closely linked and frequently co-ampli®ed genes (CDK4, SAS, and OS9 ). The 4833 bp full length OS4 cDNA sequence was submitted to GenBank (accession number: AF000152) The levels of OS4 poly(A) + RNA were twofold lower in brain and lung, fourfold lower in liver, and more than fourfold higher in pancreas, than in the remaining normal tissues. (b) OS4 transcripts was detected in these cancer cell lines at levels comparable to those observed in normal tissues. The message level was some lower in A549 relative to the other lines tested. The numbers indicate molecular markers (kb). The human b-actin probe was used as a control for loading error. The weak and strong bands below b-actin in the lanes of prostate, colon, heart, and skeletal muscle are isoforms of b-actin mRNA. W.B.C., white blood cells; muscle, skeletal muscle; HL-60: promyelocytic leukemia HL-60; Hela: HeLa cell S3; K562: chronic myelogenous leukemia K562; MOLT-4: lymphoblastic leukemia MOLT-4; Raji: Burkitt's lymphoma Raji; SW480: colorectal adenocarcinoma SW480; A549: lung carcinoma A549; G361: melanoma G361
Discussion
In this report, we have presented the features of the OS4 cDNA and ORF, and its ubiquitous expression in human normal tissues and cancer cell lines. Our homology analysis showed that OS4 and the related genes from C. elegans, S. pombe, and S. cerevisiae, probably belong to an evolutionarily conserved superfamily. Overexpression of OS4 and the closely linked gene CDK4 was revealed in three cancer cell lines with ampli®cation of these genes. In addition, we demonstrated co-ampli®cation of OS4 with CDK4 in 5/5 primary human sarcomas with known CDK4 amplification.
The full length OS4 cDNA consists of 4833-bp nucleotides which is consistent with Northern analysis detecting a message of approximately 4.8 kb in all 16 human normal tissues and 13 cancer cell lines examined. Interestingly, the GC-rich 305-bp 5'-UTR contains a multiple direct repeat clusters, suggesting a possible role in regulation of either transcription or translation of the OS4 gene. Translation of the OS4 ORF predicts a water-soluble acidic polypeptide. The presence of OS4 transcripts in several dozens of dierent human tissues including normal tissues (adult, infant, and fetal), tumor tissues, cancer cell lines, and a multiple sclerosis lesion demonstrates its ubiquitous expression. Although its function has yet to be determined, such a broad spectrum of expression suggests that OS4 has an essential role.
Using the predicted OS4 protein, we identi®ed eight genes from genomic sequences of C. elegans, S. pombe, and S. cerevisiae sharing highly conserved sequences (HC1, HC2, and HC3). According to the predicted isoelectric point, the nine proteins can be divided into three subgroups: acidic (OS4, B0379.4, SPAC2F7.02c, YLR019w, and YLL010c), basic (F45E12.1 and YHR004c), and neutral (LPE7w and T21C9.12). Because of the potential transmembrane domain in the amino terminal region of F45E12.1 and YHR004c, these two peptides are possibly membrane-associated. The highly signi®cant sequence similarity in these nine predicted proteins strongly suggests that they share the domains with common function. Currently, this superfamily of proteins contains four members from S. cerevisiae and three members from C. elegans. We expect more members to be identi®ed from other eukaryotes. In fact, several human ESTs aligned with the OS4 cDNA appear to represent additional human genes in the OS4 family.
The potential biological role of OS4 in relation to 12q13-15 ampli®cation must be considered in the context of physical mapping studies of this amplicon. We have previously demonstrated that there are two distinct core regions of ampli®cation separated by several megabases. Although each of these segments can be ampli®ed independently, they are most frequently co-ampli®ed, and the intervening region remains single copy. This pattern has been observed in both sarcomas and brain tumors (Berner et al., 1996; Reifenberger et al., 1996 . The more telomeric of these two ampli®ed segments includes the MDM2 gene which functions as a negative regulator of p53. At the present time, no additional ampli®ed genes have been identi®ed in the MDM2 core region. The second region of ampli®cation is located several Mb centromeric to MDM2 and is approximately 100 kb in size. This amplicon contains a very tightly linked cluster of genes including CDK4, OS4, SAS, and OS9 as well as several other cDNAs (Elkalhoun et al., 1997) . CDK4 is an excellent candidate target gene for this amplicon in view of its role in promoting the G1 to S phase transition through phosphorylation of the retinoblastoma protein. However, even if CDK4 is accepted as Overexpression of OS4 and CDK4 in cancer cell lines with ampli®cation of these genes. After normalization relative to b-actin, expression of OS4 and CDK4 was estimated by densitometry to be more than tenfold higher in the cell lines, NGP-127, RMS-13, and OsA-Cl with ampli®cation of these two genes than the non-ampli®ed lines, U-2 OS and HOS, and the normal tissues, spleen, pancreas, and skeletal muscle. NGP-127: neuroblastoma (Schwab et al., 1983) ; RMS-13: rhabdomyosarcoma (Roberts et al., 1989 ; OsA-C1: osteosarcoma (Roberts et al., 1989) ; U-2 OS: osteosarcoma (Ponten and Saksela, 1967) ; HOS: osteosarcoma (Rhim et al., 1975) Placenta T1  T2  T3  T4  T5 9.4 -9.4 -6.6 -4.4 -
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β-actin Figure 5 Southern detection of OS4 and CDK4 ampli®cation in human sarcomas. After normalization relative to b-actin, in comparison to placental DNA, both OS4 and CDK4 probes detected greater than ®vefold intensity in T1, T2, T3, and T5, and greater than twofold ampli®cation in T4, estimated by densitometry. T1: pleomorphic sarcoma 269; T2: malignant ®brous histocytoma 19A; T3: osteosarcoma C128; T4: osteosarcoma C206; T5: malignant schwannoma C080. 10 mg of DNA was digested with HindIII, size-fractionated on an agarose gel, and transferred to a nylon membrane for hybridization the primary target of this ampli®cation unit, it is dicult to exclude a contribution to the transformed phenotype from overexpression of nearby¯anking genes such as OS4. It thus remains necessary to characterize each gene in the core of the ampli®cation unit with regard to expression, sequence and function. In this regard OS4 is intriguing because of its remarkably high degree of sequence conservation. Although its pattern of expression appears to be ubiquitous, the levels of expression which we observed in association with gene ampli®cation are signi®cantly higher than those observed in normal tissues and might well result in a phenotypic eect. Because of these considerations, further functional studies of OS4 appear justi®ed to determine to what extent its overexpression may impact on the biological properties of tumor cells bearing ampli®cation of this region.
Materials and methods
Cell culture and isolation of RNA and cDNA
The human cancer cell lines, OsA-Cl (osteosarcoma) (Roberts et al., 1989) , RMS-13 (rhabdomyosarcoma) (Roberts et al., 1989) , NGP-127 (neuroblastoma) (Schwab et al., 1983) , HOS (osteosarcoma) (Rhim et al., 1975) (Sambrook et al., 1989) . Poly(A) + RNA was puri®ed using the FastTrack kit 2.0 (Invitrogen). Poly(A) + RNA from spleen, pancreas, and skeletal muscle were obtained from Clontech.
Generation of plasmids containing the OS4 cDNA
The cDNA library (in bacteriophage l ZAPII) highly enriched for transcribed sequences from the 12q hsr was previously described (Su et al., 1994) . The library was plated at a density of 628 plaque forming units (pfu) per 150-mm petri dish in E. coli XL1-blue cells. Plaque lifts and hybridizations were performed by standard methods (Sambrook et al., 1989) . Thirty-nine plaques were picked following hybridization with the OS4 probe and converted to pBluescript plasmids containing OS4 cDNA inserts according to the manufacturer's protocol (Stratagene). A total of 13 plasmids were used for determination of the 3'-most 1.2-kb sequence of the OS4 cDNA. Using this sequence, 13 plasmids were isolated from a spleen cDNA library using the GeneTrapper method (GIBCO BRL). These plasmids resulted in extension of the cDNA sequence to 2.8 kb. Using previously described 5' RACE methods (Su et al., 1996) , we generated 31 plasmids containing overlapping fragments of the 5'-most 2.5-kb OS4 cDNA.
Nucleotide sequence analysis
Both strands of a total of 57 plasmids containing overlapping fragments of the full length OS4 cDNA were sequenced by automated¯uorescence sequencing. Multiple sequence alignments and consensus determinations were performed with DNASTAR software (version 1.58; DNASTAR Inc.). The current sequence databases were searched by the BLASTN, BLASTP, and FASTA programs (Altschul et al., 1990) .
Northern and Southern hybridization
Human b-actin and CDK4 probes were described previously (Su et al., 1996) . The OS4 probe was a 2.7 kb OS4 cDNA. The probes were labeled by random priming (Feinberg et al., 1983) . Multiple tissue Northern membranes were obtained from Clontech. Northern and Southern hybridizations were performed by standard methods (Sambrook et al., 1989; Brown, 1993) . Filters were washed to a stringency of 0.16SSC at 428C and exposed to Kodak X-omat AR autoradiography ®lm at 7808C for various periods from 2 h to 3 days. Band intensities were measured by densitometry and analysed using IP Lab Spectrum software (Signal Analytics Co., Vienna, Virginia).
Abbreviations ORF, open reading frame; hsr, homogeneously staining region; CDK4, cyclin-dependent kinase 4; pRb, retinoblastoma protein; EST, expressed sequence tag; bp, base pairs.
